Merck Limited
Merck Limited (formerly E. Merck Limited) was set up in India in 1967; the first Merck Group company in Asia. Merck Limited went public in 1981 and was the first Merck Group company to do so. The Merck Group now holds 51% of the share capital of Merck Limited, while the remaining 49% is publicly traded on the Bombay Stock Exchange Ltd. and the National Stock Exchange of India Ltd. The company has both Pharmaceuticals and Chemicals operations.
| Facts & Figures | |
| Managing Director | Dr. Marek Dziki |
| Number of employees | Nearly 1800; including close to 600 associates (as of 22nd December 2008) |
| Sales | Rs. 3.148 million (2007) |
| Major products - Pharmaceuticals | Vitamins, Nutritional supplements, Cardiovascular Diseases, Respiratory, Hematinics, Cough & Cold, Anti-malarial, Non-Steroidal Anti-inflammatory Drugs (NSAID), Antibiotics, Oral Rehydration Salts and Encephalotropics |
| Major products - Chemicals | Life Science Solutions & Specialty Pigments |
| Research & Development | Merck’s state-of-the-art Galenic and Analytical Development Laboratory in Navi Mumbai, Maharashtra enables it to react faster to market demands, have better quality control and ensure world-class formulations by developing in-house various galenic forms like tablets, capsules, injections, syrups, dry powders, creams, etc. |
| Corporate Responsibility | The Merck India Charitable Trust Scholarship Programme was established in 2005 to provide financial aid to economically disadvantaged students in India to continue with their higher education. Following a contribution of Rs. 30 million to the corpus by Merck, the Trust has financed the education of over 100 students since its inception. |
